Heart Disease and Pregnancy

被引:30
作者
Ashrafi R. [1 ]
Curtis S.L. [1 ]
机构
[1] Congenital Cardiac Centre, Bristol Heart Institute, Bristol Royal Infirmary, Marlborough Street, Bristol
关键词
Gender; Heart disease; Pregnancy;
D O I
10.1007/s40119-017-0096-4
中图分类号
学科分类号
摘要
Cardiac disease remains a major cause of morbidity and mortality in pregnant and post-partum women, although progress has been made, with specialist joint obstetric–cardiology clinics providing an integrated, safe and personalised service to these women. As a result, fewer non-specialist cardiologists are managing women in pregnancy with cardiovascular disease. The aim of this review is to provide a brief overview of current knowledge and practice in the field, with an emphasis on the major physiological changes which occur during pregnancy, focussing on progress through the trimesters, clinical assessment in pregnancy, management of delivery (concentrating on managed vaginal delivery), drug treatment, key conditions and risk assessment. The latter factor is particularly important in terms of being able to identify high-risk women earlier and to counsel them appropriately. Pregnant women with cardiovascular conditions can, with appropriate knowledge and counselling, be managed safely in specialist multidisciplinary services, but there is a need for cardiologists to understand the key changes and risks involved in pregnancy, delivery and the post-partum period. © 2017, The Author(s).
引用
收藏
页码:157 / 173
页数:16
相关论文
共 87 条
  • [81] Soma-Pillay P., Nene Z., Mathivha T.M., Macdonald A.P., The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valves, Obstet Med, 4, pp. 24-27, (2011)
  • [82] Alshawabkeh L., Economy K.E., Valente A.M., Anticoagulation during pregnancy: evolving strategies with a focus on mechanical valves, J Am Coll Cardiol, 68, pp. 1804-1813, (2016)
  • [83] Patel J.P., Green B., Patel R.K., Marsh M.S., Davies J.G., Arya R., Population pharmacokinetics of enoxaparin during the antenatal period. Clinical perspective, Circulation, 128, pp. 1462-1469, (2013)
  • [84] Ruys T.P.E., Roos-Hesselink J.W., Pijuan-Domenech A., Vasario E., Gaisin I.R., Iung B., Freeman L.J., Gordon E.P., Pieper P.G., Hall R., Boersma E., Johnson M.R., Is a planned caesarean section in women with cardiac disease beneficial?, Heart, 101, pp. 530-536, (2015)
  • [85] Esteves-Pereira A.P., Deneux-Tharaux C., Nakamura-Pereira M., Saucedo M., Bouvier-Colle M.-H., Leal M.C., Leal MdC: caesarean delivery and postpartum maternal mortality: a population-based case control study in Brazil, PLoS One, 11, (2016)
  • [86] Ruys T.P.E., Roos-Hesselink J.W., Pijuan-Domenech A., Vasario E., Gaisin I.R., Iung B., Freeman L.J., Gordon E.P., Pieper P.G., Hall R., Boersma E., Johnson M.R., Is a planned caesarean section in women with cardiac disease beneficial?, Heart, 101, pp. 530-536, (2015)
  • [87] Cauldwell M., Steer P.J., Swan L., Uebing A., Gatzoulis M.A., Johnson M.R., The management of the third stage of labour in women with heart disease, Heart, 103, pp. 945-951, (2017)